PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 720 results · Social Media & Digital  · Clear
🔒 Subscribers only
AUTH/3778/6/23
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
An article titled ‘Exploring the potential of remote atrial fibrillation diagnosis through digital technology’ was published in Cardiac Rhythm News (August 2021).The opportunity arose after Dai…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3770/5/23
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
An anonymous complainant alleged that a Nilemdo/Nustendi promotional website suggested Nustendi could be added to statins without stating a key contraindication from the Nustendi SmPC.The contraind…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3799/7/23
Social Media & Digital Upheld 🏥 Other ▶ Video 🎙 Podcast
Grünenthal voluntary admission
Grünenthal made a voluntary admission about an employee in Market Access whose role involved calling on health professionals.The employee started employment in February 2022 but did not start/take…
Clauses: 10.2
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3834/10/23
Social Media & Digital Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
AbbVie
AbbVie made a voluntary admission after, during its response to another PMCPA case (AUTH/3834/10/23), it identified that a ‘Clear Horizons’ registration webpage for UK health professionals had …
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3728/1/23
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Bristol Myers Squibb
A complaint was made alleging promotion of Zeposia (ozanimod hydrochloride) by Bristol Myers Squibb.Complaint received: 11 January 2023.Case completed: 20 February 2024.
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3777/6/23
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AstraZeneca Trixeo eligibility checklist
An anonymous, contactable complainant (self-described health professional) challenged a UK HCP promotional website resource: a Trixeo (formoterol fumarate dihydrate/glycopyrronium/budesonide) “pa…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3801/7/23
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca
An anonymous complainant alleged a very senior UK-based AstraZeneca leader’s LinkedIn profile ‘About’ section referenced multiple AstraZeneca medicines by brand name (eg Tagrisso, Imfinzi, Im…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3729/1/23
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca
Complaint 1 (Jan 2022 webinar): A UK virtual “Early Stage Think Tank”/“Surgical Think Tank” meeting was presented as non-promotional, but the Panel considered it promotional given the conte…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3774/6/23
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca
An anonymous, contactable complainant (who later became non-contactable) complained about senior global UK-based AstraZeneca employees’ activity on LinkedIn.Two historical LinkedIn posts were cit…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3785/6/23
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK breached ABPI Code over “Trevor trusts Trelegy” website claim (AUTH/3785/6/23)
An anonymous complainant challenged promotional content for Trelegy on GSK’s HCP-facing website (GSKPro).The webpage headline claim stated: “Trevor trusts Trelegy*”, with a qualifier: “*But…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3781/6/23
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK fined for ambiguous Trelegy website claim implying significant exacerbation reduction vs unnamed
An anonymous, contactable health professional complained about a promotional claim on GSK’s HCP website (GSK.pro) for Trelegy Ellipta.The headline claim stated: “Trelegy demonstrated greater an…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3813/8/23
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca
A third-party institution posted on LinkedIn about a pre-clinical study discussing resistance to osimertinib and how it might be reversed/restored in certain EGFR-mutant lung tumours.Three UK-based…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3810/8/23
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
GSK
An anonymous, non-contactable complainant (ex-employee) alleged a GSK employee shared a LinkedIn post about Jemperli’s (dostarlimab) US licence expansion, linking to a GSK press release, and that…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3816/7/23
Social Media & Digital Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Stirling Anglian breached Clause 12.9 after omitting adverse event reporting statement from Acepiro
An anonymous, non-contactable complainant queried a digital banner advertisement for Acepiro (acetylcysteine) on a learned society’s website, noting the absence of a “safety statement” in the…
Clauses: 12.9
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3789/7/23
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Moderna
An anonymous, non-contactable complainant submitted a November 2021 presentation titled “E-concent management – Manual process”.The presentation described a regional proposal for obtaining HC…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3818/9/23
Social Media & Digital Upheld 🏥 Other ▶ Video 🎙 Podcast
Complainant v GSK
A complaint was made against GSK concerning allegations about a webpage.The PMCPA assessed whether the matter fell within the scope of the ABPI Code of Practice.
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3836/10/23
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
GSK breached ABPI Code over Zejula AE management webpage that omitted discontinuation scenarios
An anonymous, contactable health professional complained about a GSK promotional webpage for Zejula (niraparib) on the GSKPro site, titled “PRIMA AE management”.The webpage stated: “If your p…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3839/10/23
Social Media & Digital Upheld 🏥 Other ▶ Video 🎙 Podcast
Ipsen
Ipsen identified (via an internal audit) that one employee in a promotional, customer-facing role calling on health professionals in Northern Ireland had no ABPI representative exam certificate on …
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3797/7/23
Social Media & Digital Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Besins Healthcare
A health professional complained about three webpages on the “Besins Hormone Academy” website, alleging the promotional nature was disguised because the site did not explicitly state it was pro…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3820/9/23
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Daiichi Sankyo
An anonymous, non-contactable complainant alleged Daiichi Sankyo was using AI technology to record healthcare professional (HCP) calls “covertly”, stating it was for representative training.Dai…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3823/9/23
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
GSK LinkedIn ‘likes’ on US momelotinib approval posts
An anonymous, non-contactable complainant alleged LinkedIn activity by GSK staff amounted to promotion to the public and lacked obligatory information (“No PI or black triangle”). The LinkedIn …
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3812/8/23
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Proveca
An anonymous, contactable complainant (a member of the public) said Google searches for “Sialanar” and “glycopyrronium” surfaced Proveca links that felt like promotion to the public.The com…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3792/7/23
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK value.gsk COPD landing page
An anonymous, contactable health professional complained about the landing page of GSK’s value.gsk promotional website for COPD medicines optimisation. The page listed five GSK respiratory produc…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3846/11/23
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
AstraZeneca breached Clauses 6.1 and 5.1 after Calquence dosing leaflet omitted monitoring caveat fo
An anonymous, contactable health professional complained about an 8-page Calquence (acalabrutinib) tablet dosing resource (GB-48523; date of preparation September 2023).Page 4 stated: “No dose ad…
Clauses: NONE
2023 🔒 Subscribe
← Prev 1 2 3 4 5 6 7 Next → Page 4 of 30 — 720 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews